Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis
Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis
Objective: epidemiological studies have reported an association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease (MASLD). However, the magnitude of the risk and whether this risk changes with the severity of MASLD remains uncertain. We performed a meta-analysis of observational studies to quantify the magnitude of the association between primary hypothyroidism and the risk of MASLD.
Design: we systematically searched PubMed, Scopus and Web of Science from database inception to 31 January 2024, using predefined keywords to identify observational studies in which MASLD was diagnosed by liver biopsy, imaging or International Classification of Diseases codes. A meta-analysis was performed using random-effects modelling.
Results: we identified 24 cross-sectional and 4 longitudinal studies with aggregate data on ∼76.5 million individuals. Primary hypothyroidism (defined as levothyroxine replacement treatment, subclinical hypothyroidism or overt hypothyroidism) was associated with an increased risk of prevalent MASLD (n=24 studies; random-effects OR 1.43, 95% CI 1.23 to 1.66; I 2=89%). Hypothyroidism was also associated with a substantially higher risk of metabolic dysfunction-associated steatohepatitis or advanced fibrosis (n=5 studies; random-effects OR 2.84, 95% CI 2.07 to 3.90; I 2=0%). Meta-analysis of data from four longitudinal studies showed that there was a marginally non-significant association between hypothyroidism and risk of developing MASLD over a median 4.5-year follow-up (random-effects HR 1.39, 95% CI 0.98 to 1.97; I 2=85%). Sensitivity analyses did not modify these findings. The funnel plot did not reveal any significant publication bias.
Conclusion: this large and updated meta-analysis provides evidence that primary hypothyroidism is significantly associated with both an increased presence of and histological severity of MASLD.
meta-analysis, nonalcoholic steatohepatitis
1554-1561
Mantovani, Alessandro
9699ef1b-870b-4ac5-8b68-2dc208ebfbe9
Csermely, Alessandro
ddd37926-ccad-42b9-8dfe-c31338af358c
Bilson, Josh
a99f9320-335c-47c8-bf30-07df48a5467d
Borella, Nicolò
b1138463-05ff-4e09-9602-3c80f9d62dd3
Enrico, Scoccia
e9447af2-b5c4-453b-95ca-539390e0317c
Pecoraro, Barbara
dea16138-0790-4a90-9d1f-b7ac9c28aa39
Shtembari, Emigela
9d8c278f-399f-47dc-a792-2efde7854d63
Morandin, Riccardo
69a93b07-f877-4a91-9c80-7bb1c84681e7
Polyzos, Stergios A.
a490a385-b3bb-4c46-a2fe-e2dbd250619b
Valenti, Luca
1f9a90ab-126c-4c4a-bb28-30387daec9d5
Tilg, Herbert
7251227e-9a2f-415d-8d32-48a2f715aee5
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Targher, Giovanni
62175c57-74bf-4087-a0ae-07ca6cf08179
8 August 2024
Mantovani, Alessandro
9699ef1b-870b-4ac5-8b68-2dc208ebfbe9
Csermely, Alessandro
ddd37926-ccad-42b9-8dfe-c31338af358c
Bilson, Josh
a99f9320-335c-47c8-bf30-07df48a5467d
Borella, Nicolò
b1138463-05ff-4e09-9602-3c80f9d62dd3
Enrico, Scoccia
e9447af2-b5c4-453b-95ca-539390e0317c
Pecoraro, Barbara
dea16138-0790-4a90-9d1f-b7ac9c28aa39
Shtembari, Emigela
9d8c278f-399f-47dc-a792-2efde7854d63
Morandin, Riccardo
69a93b07-f877-4a91-9c80-7bb1c84681e7
Polyzos, Stergios A.
a490a385-b3bb-4c46-a2fe-e2dbd250619b
Valenti, Luca
1f9a90ab-126c-4c4a-bb28-30387daec9d5
Tilg, Herbert
7251227e-9a2f-415d-8d32-48a2f715aee5
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Targher, Giovanni
62175c57-74bf-4087-a0ae-07ca6cf08179
Mantovani, Alessandro, Csermely, Alessandro, Bilson, Josh, Borella, Nicolò, Enrico, Scoccia, Pecoraro, Barbara, Shtembari, Emigela, Morandin, Riccardo, Polyzos, Stergios A., Valenti, Luca, Tilg, Herbert, Byrne, Christopher D. and Targher, Giovanni
(2024)
Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis.
Gut, 73 (9), , [gutjnl-2024-332491].
(doi:10.1136/gutjnl-2024-332491).
Abstract
Objective: epidemiological studies have reported an association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease (MASLD). However, the magnitude of the risk and whether this risk changes with the severity of MASLD remains uncertain. We performed a meta-analysis of observational studies to quantify the magnitude of the association between primary hypothyroidism and the risk of MASLD.
Design: we systematically searched PubMed, Scopus and Web of Science from database inception to 31 January 2024, using predefined keywords to identify observational studies in which MASLD was diagnosed by liver biopsy, imaging or International Classification of Diseases codes. A meta-analysis was performed using random-effects modelling.
Results: we identified 24 cross-sectional and 4 longitudinal studies with aggregate data on ∼76.5 million individuals. Primary hypothyroidism (defined as levothyroxine replacement treatment, subclinical hypothyroidism or overt hypothyroidism) was associated with an increased risk of prevalent MASLD (n=24 studies; random-effects OR 1.43, 95% CI 1.23 to 1.66; I 2=89%). Hypothyroidism was also associated with a substantially higher risk of metabolic dysfunction-associated steatohepatitis or advanced fibrosis (n=5 studies; random-effects OR 2.84, 95% CI 2.07 to 3.90; I 2=0%). Meta-analysis of data from four longitudinal studies showed that there was a marginally non-significant association between hypothyroidism and risk of developing MASLD over a median 4.5-year follow-up (random-effects HR 1.39, 95% CI 0.98 to 1.97; I 2=85%). Sensitivity analyses did not modify these findings. The funnel plot did not reveal any significant publication bias.
Conclusion: this large and updated meta-analysis provides evidence that primary hypothyroidism is significantly associated with both an increased presence of and histological severity of MASLD.
Text
Association Between Hypothyroidism and Metabolic Dysfunction_R1_marked copy
- Accepted Manuscript
Text
Figure 1
- Accepted Manuscript
Text
Figure 2_R1
- Accepted Manuscript
Text
Figure 3
- Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
ONLINE_ONLY SUPPLEMENTARY MATERIAL_R1
- Accepted Manuscript
Restricted to Repository staff only
Request a copy
Show all 5 downloads.
More information
Accepted/In Press date: 15 May 2024
e-pub ahead of print date: 23 May 2024
Published date: 8 August 2024
Additional Information:
Publisher Copyright:
© 2024 BMJ Publishing Group. All rights reserved.
Keywords:
meta-analysis, nonalcoholic steatohepatitis
Identifiers
Local EPrints ID: 490356
URI: http://eprints.soton.ac.uk/id/eprint/490356
ISSN: 1468-3288
PURE UUID: 84ac356d-ee54-40ec-82e2-eaee83c85c2f
Catalogue record
Date deposited: 23 May 2024 17:13
Last modified: 30 Nov 2024 03:12
Export record
Altmetrics
Contributors
Author:
Alessandro Mantovani
Author:
Alessandro Csermely
Author:
Josh Bilson
Author:
Nicolò Borella
Author:
Scoccia Enrico
Author:
Barbara Pecoraro
Author:
Emigela Shtembari
Author:
Riccardo Morandin
Author:
Stergios A. Polyzos
Author:
Luca Valenti
Author:
Herbert Tilg
Author:
Giovanni Targher
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics